Wells Fargo’s Immunome IMNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $388K | Buy |
41,761
+5,661
| +16% | +$52.6K | ﹤0.01% | 3960 |
|
|
2025
Q1 | $243K | Buy |
36,100
+9,893
| +38% | +$66.6K | ﹤0.01% | 4130 |
|
|
2024
Q4 | $278K | Buy |
26,207
+8,190
| +45% | +$87K | ﹤0.01% | 4104 |
|
|
2024
Q3 | $263K | Sell |
18,017
-526
| -3% | -$7.69K | ﹤0.01% | 4013 |
|
|
2024
Q2 | $224K | Buy |
18,543
+14,329
| +340% | +$173K | ﹤0.01% | 4090 |
|
|
2024
Q1 | $104K | Buy |
4,214
+2,196
| +109% | +$54.2K | ﹤0.01% | 4502 |
|
|
2023
Q4 | $21.6K | Buy |
2,018
+170
| +9% | +$1.82K | ﹤0.01% | 5180 |
|
|
2023
Q3 | $15.4K | Sell |
1,848
-9
| -0.5% | -$75 | ﹤0.01% | 5319 |
|
|
2023
Q2 | $14.7K | Buy |
1,857
+3
| +0.2% | +$24 | ﹤0.01% | 5516 |
|
|
2023
Q1 | $9.25K | Buy |
1,854
+1
| +0.1% | +$5 | ﹤0.01% | 5567 |
|
|
2022
Q4 | $4.1K | Buy |
1,853
+2
| +0.1% | +$4 | ﹤0.01% | 5501 |
|
|
2022
Q3 | $8K | Sell |
1,851
-1
| -0.1% | -$4 | ﹤0.01% | 5432 |
|
|
2022
Q2 | $6K | Buy |
1,852
+6
| +0.3% | +$19 | ﹤0.01% | 5649 |
|
|
2022
Q1 | $10K | Buy |
1,846
+1,785
| +2,926% | +$9.67K | ﹤0.01% | 5913 |
|
|
2021
Q4 | $1K | Buy |
61
+2
| +3% | +$33 | ﹤0.01% | 6459 |
|
|
2021
Q3 | $1K | Buy |
59
+30
| +103% | +$508 | ﹤0.01% | 6383 |
|
|
2021
Q2 | $1K | Sell |
29
-635
| -96% | -$21.9K | ﹤0.01% | 6330 |
|
|
2021
Q1 | $22K | Sell |
664
-619
| -48% | -$20.5K | ﹤0.01% | 5756 |
|
|
2020
Q4 | $12K | Buy |
+1,283
| New | +$12K | ﹤0.01% | 5717 |
|